Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73)
暂无分享,去创建一个
John M. Davis | J. Hibbeln | C. Suchindran | S. Broste | R. Frantz | C. Ramsden | Daisy Zamora | Sharon F Majchrzak-Hong | K. Faurot | Amit Ringel | Sharon F. Majchrzak-Hong
[1] S. Rapoport,et al. Dietary linoleic acid-induced alterations in pro- and anti-nociceptive lipid autacoids , 2016, Molecular pain.
[2] John M. Davis,et al. Diet-induced changes in n-3- and n-6-derived endocannabinoids and reductions in headache pain and psychological distress. , 2015, The journal of pain : official journal of the American Pain Society.
[3] G. Pennings,et al. Governing the Postmortem Procurement of Human Body Material for Research , 2015, Kennedy Institute of Ethics journal.
[4] C. McClain,et al. Transient receptor potential vanilloid 1 gene deficiency ameliorates hepatic injury in a mouse model of chronic binge alcohol-induced alcoholic liver disease. , 2015, The American journal of pathology.
[5] Indra Ramasamy,et al. Recent advances in physiological lipoprotein metabolism , 2014, Clinical chemistry and laboratory medicine.
[6] W. Willett,et al. Dietary Linoleic Acid and Risk of Coronary Heart Disease: A Systematic Review and Meta-Analysis of Prospective Cohort Studies , 2014, Circulation.
[7] D. Mozaffarian,et al. Circulating Omega-6 Polyunsaturated Fatty Acids and Total and Cause-Specific Mortality: The Cardiovascular Health Study , 2014, Circulation.
[8] E. Schaefer,et al. The composition and metabolism of large and small LDL , 2014, Current opinion in lipidology.
[9] Simon G Thompson,et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. , 2014, Annals of internal medicine.
[10] P. Lory,et al. Modulation of T-type calcium channels by bioactive lipids , 2014, Pflügers Archiv - European Journal of Physiology.
[11] P. Kris-Etherton,et al. Limitations of observational evidence: implications for evidence-based dietary recommendations. , 2014, Advances in nutrition.
[12] D. Mozaffarian,et al. Circulating and Dietary Omega‐3 and Omega‐6 Polyunsaturated Fatty Acids and Incidence of CVD in the Multi‐Ethnic Study of Atherosclerosis , 2013, Journal of the American Heart Association.
[13] S. Gaylord,et al. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: A randomized trial , 2013, PAIN®.
[14] P. Legrand,et al. Comparative effects of well-balanced diets enriched in α-linolenic or linoleic acids on LC-PUFA metabolism in rat tissues. , 2013, Prostaglandins, leukotrienes, and essential fatty acids.
[15] C. McClain,et al. Ethanol and dietary unsaturated fat (corn oil/linoleic acid enriched) cause intestinal inflammation and impaired intestinal barrier defense in mice chronically fed alcohol. , 2013, Alcohol.
[16] H. Naci,et al. Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials , 2013, European journal of preventive cardiology.
[17] John M Davis,et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis , 2013, BMJ : British Medical Journal.
[18] J. M. Mata-Granados,et al. Short-term comparative study of the influence of fried edible oils intake on the metabolism of essential fatty acids in obese individuals. , 2013, Food chemistry.
[19] Alan F. Karr,et al. Deming, data and observational studies: A process out of control and needing fixing , 2013 .
[20] S. Marmesat,et al. Influence of fatty acid composition on chemical changes in blends of sunflower oils during thermoxidation and frying. , 2012, Food chemistry.
[21] S. Rapoport,et al. Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans. , 2012, Prostaglandins, leukotrienes, and essential fatty acids.
[22] Richard Lehman,et al. Missing clinical trial data , 2012, BMJ : British Medical Journal.
[23] P. Guesnet,et al. α-Linolenate reduces the dietary requirement for linoleate in the growing rat. , 2011, Prostaglandins, leukotrienes, and essential fatty acids.
[24] M. Febbraio,et al. The emerging roles of fatty acid translocase/CD36 and the aryl hydrocarbon receptor in fatty liver disease , 2011, Experimental biology and medicine.
[25] S. Stanley Young,et al. Deming, data and observational studies , 2011 .
[26] J. Hibbeln,et al. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. , 2011, The American journal of clinical nutrition.
[27] S. Howlett,et al. Blood Pressure in Relation to Age and Frailty , 2011, Canadian geriatrics journal : CGJ.
[28] F. Godlee,et al. Missing clinical trial data: setting the record straight , 2010, BMJ : British Medical Journal.
[29] S. Hazen,et al. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[S] , 2010, Journal of Lipid Research.
[30] S. Eaton,et al. Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet , 2010, British Journal of Nutrition.
[31] B. Baune,et al. Review: Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis , 2010, Therapeutic advances in endocrinology and metabolism.
[32] S. Weintraub,et al. Heat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodents. , 2010, The Journal of clinical investigation.
[33] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[34] A. Akopian,et al. Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia , 2009, Proceedings of the National Academy of Sciences.
[35] W. Willett. The role of dietary n-6 fatty acids in the prevention of cardiovascular disease , 2007, Journal of cardiovascular medicine.
[36] L. Ferrucci,et al. Phenotype of frailty: characterization in the women's health and aging studies. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.
[37] Ulrike Peters,et al. Is It Time to Abandon the Food Frequency Questionnaire? , 2005, Cancer Epidemiology Biomarkers & Prevention.
[38] J. Manson,et al. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study. , 2005, American journal of epidemiology.
[39] R. Mensink,et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. , 2003, The American journal of clinical nutrition.
[40] Heidi D Nelson,et al. Postmenopausal hormone replacement therapy: scientific review. , 2002, JAMA.
[41] Louise Smyth,et al. Dietary hydroxy fatty acids are absorbed in humans: implications for the measurement of 'oxidative stress' in vivo. , 2002, Free radical biology & medicine.
[42] L. Fried,et al. Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[43] F. Grodstein,et al. Invited commentary: can selection bias explain the cardiovascular benefits of estrogen replacement therapy? , 1996, American journal of epidemiology.
[44] D. Spady. Hepatic Clearance of Plasma Low Density Lipoproteins , 1992, Seminars in liver disease.
[45] B. Psaty,et al. Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group. , 1992, The American journal of cardiology.
[46] G A Colditz,et al. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. , 2004, Preventive medicine.
[47] G. Colditz,et al. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence☆☆☆ , 1991 .
[48] J P Matts,et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) , 1990, The New England journal of medicine.
[49] J. Sampugna,et al. Isomeric trans fatty acids in the U.S. diet. , 1990, Journal of the American College of Nutrition.
[50] L. Gatewood,et al. Test of Effect of Lipid Lowering by Diet on Cardiovascular Risk: The Minnesota Coronary Survey , 1989, Arteriosclerosis.
[51] J. Hupp. Lowering Blood Cholesterol to Prevent Heart Disease , 1985, International Journal of Technology Assessment in Health Care.
[52] P. Sastry,et al. Lipids of nervous tissue: composition and metabolism. , 1985, Progress in lipid research.
[53] A. Caplan. Morality dissected: a plea for reform of current policies with respect to autopsy. , 1984, Human pathology.
[54] L. Thompson,et al. Lipid Changes in French Fries and Heated Oils During Commercial Deep Frying and Their Nutritional and Toxicological Implications , 1983 .
[55] R. Sherwin. Controlled trials of the diet-heart hypothesis: some comments on the experimental unit. , 1978, American journal of epidemiology.
[56] G. Camejo,et al. The affinity of low density lipoproteins for an arterial macromolecular complex. A study in ischemic heart disease and controls. , 1976, Atherosclerosis.
[57] R. Ross. The case of prevention of coronary heart disease. , 1975, Circulation.
[58] H. Feigenbaum. Echocardiographic examination of the left ventricle. , 1975, Circulation.
[59] A Keys,et al. Bias and misrepresentation revisited: "perspective" on saturated fat. , 1974, The American journal of clinical nutrition.
[60] The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group. , 1973, JAMA.
[61] J. Stamler. The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group. , 1972, JAMA.
[62] M. Armstrong,et al. Regression of Coronary Atheromatosis in Rhesus Monkeys , 1970, Circulation research.
[63] The Coronary Drug Project. Initial findings leading to modifications of its research protocol. , 1970, JAMA.
[64] G. Getz,et al. A dynamic pathology of atherosclerosis , 1969 .
[65] G. Getz,et al. A dynamic pathology of arteriosclerosis. , 1969, The American journal of medicine.
[66] F. Grande,et al. Serum cholesterol response to changes in the diet: I. Iodine value of dietary fat versus 2S-P. , 1965, Metabolism: clinical and experimental.
[67] A. Keys,et al. Serum cholesterol response to changes in the diet: IV. Particular saturated fatty acids in the diet. , 1965, Metabolism: clinical and experimental.
[68] J. Edwards,et al. The Spectrum of Coronary Heart Disease in a Community of 30,000: A Clinicopathologic Study , 1962, Circulation.
[69] A. Keys,et al. Hydrogenated fats in the diet and lipids in the serum of man. , 1961, The Journal of nutrition.
[70] I. Browne,et al. The management of the acute withdrawal phase in alcoholism. , 1959, Lancet.
[71] A. Keys,et al. Prediction of serum-cholesterol responses of man to changes in fats in the diet. , 1957, Lancet.